Picture of StenoCare A/S logo

STENO StenoCare A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Stenocare Initiates Guidance

March 10 (Reuters) - Stenocare A/S  STENO.CO :
    * STENOCARE INITIATES GUIDANCE: 15-20MDKK IN ANNUAL REVENUE
RUN
RATE BY END OF 2022
    * TODAY WE ALSO INTRODUCE, FOR FIRST TIME, AN OFFICIAL
REVENUE
GUIDANCE BY STATING THAT WE EXPECT TO FINISH CURRENT YEAR WITH A
RUN-RATE OF 15-20 MILLION DKK.
    * THIS MEANS THAT - IF REALIZED - WE WILL ENTER 2023 WITH A
REVENUE BASE IN THIS RANGE.
    * HAS SUCCESSFULLY REACHED TWO IMPORTANT LICENSE MILESTONES
DURING
Q1 2022
    * BY END OF YEAR EXPECTED SALES RUN RATE (CALCULATED AS Q4
TIMES
4) IS SET AT 15 TO 20 MILLION DKK, UP FROM TOTAL SALES IN 2021
OF 1,9 MILLION DKK

Source text for Eikon:  ID:nWkrsQD28 
Further company coverage:  STENO.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on StenoCare A/S

See all news